The current role of androgen deprivation in patients undergoing dose-escalated external beam radiation therapy for clinically localized prostate cancer.

Prostate Cancer · 2012 · PMC3348643 · PMID 22619727

Europe PMC DOI

hedged sentence

0.0507

closest p · 1.0× alpha

0.0507

boldest claim

The sentences

a strong trendP = 0.0507so close (0.05 < p ≤ 0.1)

When adjusting for higher PSA (greater than 20) and for higher Gleason scores (>7), there was no obvious benefit for high risk patients when long-term ADT was added to EBRT at doses greater than 73.8 Gy, although there was a strong trend ( P = 0.0507).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.